SB257
Health insurance; requirements for certain opioid antagonists.
Status:
Passed
Latest Action:
March 12, 2026
Senate: House substitute agreed to by Senate (39-Y 1-N 0-A)
Chief Patron:
Barbara Favola (D)
Session:
2026 Regular Session
Summary
As Passed House of Origin. Health insurance; coverage for prescription and nonprescription opioid antagonists.
Requires each health insurer, corporation providing health care subscription plans, and health maintenance organization whose policy, contract, or plan includes coverage for prescription drugs to include coverage for (i) at least one other opioid antagonist used for overdose reversal dispensed pursuant to an oral, written, or standing order of a ... (More) prescriber on the lowest cost tier of the insurer's, corporation's, or health maintenance organization's prescription drug formulary and (ii) at least one nonprescription opioid antagonist used for overdose reversal that is available over the counter. The bill provides that such coverage shall be exempt from any prior authorization or step therapy requirement on coverage of benefits. As introduced, this bill was a recommendation of the Joint Commission on Health Care. (Less)-
Bill History
- 01/12/2026 - Senate: Prefiled and ordered printed; Offered 01-14-2026 26104746D
- 01/12/2026 - Senate: Referred to Committee on Commerce and Labor
- 01/23/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB257)
- 02/02/2026 - Senate: Senate committee offered
- 02/02/2026 - Senate: Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations (10-Y 2-N 1-A)
- 02/02/2026 - Senate: Rereferred to Finance and Appropriations
- 02/03/2026 - Senate: Committee substitute printed 26106753D-S1
- 02/04/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB257)
- 02/11/2026 - Senate: Reported from Finance and Appropriations (15-Y 0-N)
- 02/12/2026 - Senate: Rules suspended
- 02/12/2026 - Senate: Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
- 02/12/2026 - Senate: Passed by for the day Block Vote (Voice Vote)
- 02/13/2026 - Senate: Read second time
- 02/13/2026 - Senate: Committee substitute agreed to (Voice Vote)
- 02/13/2026 - Senate: Engrossed by Senate - committee substitute (Voice Vote)
- 02/16/2026 - Senate: Read third time and passed Senate (37-Y 1-N 0-A)
- 02/19/2026 - House: Placed on Calendar
- 02/19/2026 - House: Read first time
- 02/19/2026 - House: Referred to Committee on Labor and Commerce
- 02/23/2026 - House: Placed on Labor and Commerce Agenda
- 02/24/2026 - House: House subcommittee offered
- 02/24/2026 - House: Assigned HCL sub: Subcommittee #1
- 02/24/2026 - House: Subcommittee recommends reporting with substitute and referring to Appropriations (6-Y 0-N)
- 02/25/2026 - House: Placed on Labor and Commerce Agenda
- 02/26/2026 - House: Reported from Labor and Commerce with substitute and referred to Appropriations (21-Y 0-N)
- 02/26/2026 - House: Referred to Committee on Appropriations
- 02/27/2026 - House: Assigned HAPP sub: Health & Human Resources
- 02/27/2026 - House: Committee substitute printed 26108572D-H1
- 03/04/2026 - House: Placed on Appropriations Agenda
- 03/04/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB257)
- 03/09/2026 - House: Placed on Appropriations Agenda
- 03/09/2026 - House: Reported from Appropriations with substitute (22-Y 0-N)
- 03/09/2026 - House: Committee substitute printed 26109143D-H2
- 03/10/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB257)
- 03/11/2026 - House: Read second time
- 03/12/2026 - House: Read third time
- 03/12/2026 - House: committee substitute rejected
- 03/12/2026 - House: committee substitute agreed to
- 03/12/2026 - House: Engrossed by House - committee substitute
- 03/12/2026 - House: Passed House with substitute (96-Y 0-N 0-A)
- 03/12/2026 - Senate: House substitute agreed to by Senate (39-Y 1-N 0-A)
